HF
AMRI

Hoxton Financial’s Albany Molecular Research Inc AMRI Stock Holding History

Hoxton Financial’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-513
Closed -$5K – 669
2013
Q4 		$5K Buy
513
+433
+541% +$5.23K ﹤0.01% 540
2013
Q3 		$1K Buy
+80
New +$984 ﹤0.01% 446

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Hoxton Financial's AMRI Position: Q1 2014 in Review

Hoxton Financial sold out of Albany Molecular Research Inc (AMRI) in Q1 2014, closing a stake of 513 shares — an estimated $5K sold.

Hoxton Financial first reported a position in AMRI in Q3 2013 and held it in 2 quarters. The position peaked at $5K in Q4 2013. 113 funds tracked by Wall St. Rank hold AMRI as of Q1 2014.

  • Hoxton Financial reported no remaining Albany Molecular Research Inc position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 513 Albany Molecular Research Inc shares in Q1 2014, an estimated $5K.
  • Hoxton Financial first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 2 quarters.
  • Hoxton Financial's Albany Molecular Research Inc position peaked at $5K in Q4 2013.
  • 113 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.